Company intelligence / Profile preview

BullFrog AI

Gaithersburg, Maryland, United Statesbullfrogai.com ↗

Ownership: Public · BFRG
Development stage: Other

Overview

BullFrog AI leverages its proprietary explainable AI platform, bfLEAP, to analyze biological, clinical, and real-world data in drug discovery and development—primarily for target identification, patient stratification, and indication expansion. As of August 2025, there are no publicly disclosed clinical results from internal drug candidates; the company functions primarily as an enabling technology/platform provider for biopharma R&D.[1][2][4][5]

Industry: Drug Discovery Services

Financials

Market cap: $9.1M
Total revenue: $116.7K
Enterprise value: $2.3M

Beyond the preview

Go deeper on BullFrog AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BullFrog AI.